E. Thomas Danielsen

E. Thomas Danielsen, PhD, is a seasoned researcher in the field of biology and biochemistry, currently serving as a Senior Research Scientist at Novo Nordisk since June 2024. Prior to this role, Danielsen was a Project Lead at 2cureX, specializing in precision medicine and functional drug testing for colorectal cancer treatments. Previously, Danielsen held positions as a Senior R&D Scientist and assay biochemist at Qlife, focusing on isothermal PCR tests and SARS-CoV-2 assays. E. Thomas Danielsen's research experience includes a postdoctoral fellowship at The Francis Crick Institute and various academic positions at the University of Copenhagen, where significant studies on inter-organ communication and steroid hormone regulation were conducted. Danielsen's educational background comprises a PhD and MSc from the University of Copenhagen, complemented by a BSc in Biochemistry from the same institution.